Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.68
+0.17 (2.00%)
Mar 11, 2026, 11:51 AM EDT - Market open
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$758,700
Market Cap
27.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 60 | 2 | 3.45% |
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | 74 | 54 | 270.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Senti Biosciences | 34 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Skye Bioscience | 16 |
| FibroBiologics | 15 |
PASG News
- 8 days ago - Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 20 days ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 months ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 5 months ago - Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 8 months ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire